Thyroid Cancers

Also known as: Cancer of Thyroid / Thyroid Gland Cancer / Thyroid Cancer / Cancer, Thyroid / Malignant neoplasm of thyroid gland / Thyroid neoplasms malignant / Primary malignant neoplasm of thyroid gland (disorder) / Thyroid neoplasm malignant / Malignant tumor of thyroid gland (disorder) / Malignant tumour of thyroid gland

Drug	Drug Name	Drug Description
DB04465	Lactose	An additive and filler found in various products to maintain structure and consistency.
DB00279	Liothyronine	A thyroid hormone replacement therapy used to treat hypothyroidism, to suppress TSH, and to help in the diagnosis of hyperthyroidism.
DB06715	Potassium Iodide	An oral antithyroid agent used for the prevention of radioactive iodine uptake into the thyroid gland during a nuclear radiation emergency.
DB00024	Thyrotropin alfa	A recombinant form of thyroid stimulating hormone used in diagnostic testing for thyroid cancer and alongside radioactive agents to destroy thyroid tissue.

Drug	Drug Name	Target	Type
DB04465	Lactose	Beta-galactosidase	target
DB04465	Lactose	Glycosyltransferase 6 domain-containing protein 1	target
DB04465	Lactose	Glycolipid transfer protein	target
DB04465	Lactose	Hydrolase	target
DB04465	Lactose	Endo-1,4-beta-xylanase A	target
DB04465	Lactose	Galectin-3	target
DB04465	Lactose	Sialidase	target
DB04465	Lactose	Beta-galactosidase	target
DB00279	Liothyronine	Thyroid hormone receptor beta	target
DB00279	Liothyronine	Thyroid hormone receptor alpha	target
DB00279	Liothyronine	Thyroxine-binding globulin	carrier
DB00279	Liothyronine	Transthyretin	carrier
DB00279	Liothyronine	Serum albumin	carrier
DB00279	Liothyronine	P-glycoprotein 1	transporter
DB00279	Liothyronine	Solute carrier family 22 member 8	transporter
DB00279	Liothyronine	Monocarboxylate transporter 10	transporter
DB00279	Liothyronine	Solute carrier organic anion transporter family member 4A1	transporter
DB00279	Liothyronine	Solute carrier organic anion transporter family member 1C1	transporter
DB00279	Liothyronine	Solute carrier organic anion transporter family member 1A2	transporter
DB00279	Liothyronine	Sodium/bile acid cotransporter	transporter
DB00279	Liothyronine	Solute carrier organic anion transporter family member 4C1	transporter
DB00279	Liothyronine	Solute carrier organic anion transporter family member 1B3	transporter
DB00279	Liothyronine	Solute carrier organic anion transporter family member 1B1	transporter
DB00279	Liothyronine	Large neutral amino acids transporter small subunit 1	transporter
DB00279	Liothyronine	Proliferating cell nuclear antigen	target
DB00279	Liothyronine	UDP-glucuronosyltransferase 1-1	enzyme
DB06715	Potassium Iodide	Tyrosine	target
DB00024	Thyrotropin alfa	Thyrotropin receptor	target

Drug	Drug Name	Phase	Status	Count
DB00307	Bexarotene	0	Completed	1
DB11714	Durvalumab	0	Active Not Recruiting	1
DB09293	Iodide I-131	0	Active Not Recruiting	1
DB00928	Azacitidine	1	Completed	1
DB11105	Benzalkonium	1	Recruiting	1
DB00112	Bevacizumab	1	Completed	1
DB11967	Binimetinib	1	Recruiting	1
DB00002	Cetuximab	1	Recruiting	1
DB00515	Cisplatin	1	Completed	1
DB12483	Copanlisib	1	Active Not Recruiting	1
DB01248	Docetaxel	1	Completed	1
DB11718	Encorafenib	1	Recruiting	1
DB00530	Erlotinib	1	Completed	1
DB00451	Levothyroxine	1	Withdrawn	1
DB17489	PF-07799933	1	Recruiting	2
DB16038	PLX8394	1	Terminated	1
DB06589	Pazopanib	1	Completed	1
DB09421	Protirelin	1	Withdrawn	1
DB17082	Tinlorafenib	1	Recruiting	1
DB08911	Trametinib	1	Completed	1
DB08881	Vemurafenib	1	Active Not Recruiting	1
DB08881	Vemurafenib	1	Completed	1
DB11595	Atezolizumab	1 / 2	Recruiting	1
DB11945	Avelumab	1 / 2	Recruiting	1
DB01101	Capecitabine	1 / 2	Terminated	1
DB00851	Dacarbazine	1 / 2	Terminated	1
DB17464	ETBX-011	1 / 2	Completed	1
DB16156	Enapotamab vedotin	1 / 2	Completed	1
DB00619	Imatinib	1 / 2	Terminated	1
DB16479	Inbakicept	1 / 2	Completed	1
DB01229	Paclitaxel	1 / 2	Recruiting	2
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB08896	Regorafenib	1 / 2	Recruiting	1
DB17384	Tinengotinib	1 / 2	Recruiting	2
DB08911	Trametinib	1 / 2	Not Yet Recruiting	1
DB12001	Abemaciclib	2	Suspended	1
DB11885	Anlotinib	2	Active Not Recruiting	1
DB11885	Anlotinib	2	Recruiting	2
DB00112	Bevacizumab	2	Terminated	1
DB11666	Buparlisib	2	Unknown Status	1
DB08875	Cabozantinib	2	Terminated	1
DB14776	Camrelizumab	2	Not Yet Recruiting	1
DB01101	Capecitabine	2	Completed	1
DB08912	Dabrafenib	2	Recruiting	3
DB08912	Dabrafenib	2	Unknown Status	1
DB06643	Denosumab	2	Completed	1
DB09341	Dextrose, unspecified form	2	Recruiting	1
DB01248	Docetaxel	2	Recruiting	1
DB05928	Dovitinib	2	Completed	1
DB00997	Doxorubicin	2	Completed	1
DB00997	Doxorubicin	2	Terminated	1
DB01590	Everolimus	2	Active Not Recruiting	1
DB01590	Everolimus	2	Completed	2
DB01590	Everolimus	2	Suspended	1
DB00441	Gemcitabine	2	Terminated	1
DB00619	Imatinib	2	Terminated	1
DB09293	Iodide I-131	2	Not Yet Recruiting	1
DB09293	Iodide I-131	2	Recruiting	1
DB06186	Ipilimumab	2	Active Not Recruiting	1
DB11733	Irofulven	2	Completed	1
DB09078	Lenvatinib	2	Completed	3
DB09078	Lenvatinib	2	Suspended	1
DB09078	Lenvatinib	2	Terminated	1
DB00451	Levothyroxine	2	Recruiting	1
DB00279	Liothyronine	2	Recruiting	1
DB14509	Lithium carbonate	2	Completed	1
DB05575	Motesanib	2	Completed	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB00526	Oxaliplatin	2	Terminated	1
DB01229	Paclitaxel	2	Unknown Status	1
DB06663	Pasireotide	2	Completed	1
DB09037	Pembrolizumab	2	Recruiting	3
DB00642	Pemetrexed	2	Unknown Status	1
DB16747	Penpulimab	2	Recruiting	1
DB00556	Perflutren	2	Recruiting	1
DB08896	Regorafenib	2	Recruiting	1
DB14765	Rivoceranib	2	Completed	1
DB14765	Rivoceranib	2	Not Yet Recruiting	1
DB14765	Rivoceranib	2	Unknown Status	1
DB11836	Sapanisertib	2	Active Not Recruiting	1
DB15685	Selpercatinib	2	Not Yet Recruiting	1
DB00398	Sorafenib	2	Active Not Recruiting	1
DB00398	Sorafenib	2	Completed	3
DB00398	Sorafenib	2	Terminated	1
DB14892	Spartalizumab	2	Recruiting	1
DB15106	Surufatinib	2	Unknown Status	1
DB06287	Temsirolimus	2	Completed	1
DB00024	Thyrotropin alfa	2	Completed	1
DB00024	Thyrotropin alfa	2	Not Yet Recruiting	1
DB00024	Thyrotropin alfa	2	Recruiting	1
DB04960	Tipifarnib	2	Completed	1
DB14922	Tislelizumab	2	Recruiting	1
DB15043	Toripalimab	2	Unknown Status	1
DB08911	Trametinib	2	Recruiting	3
DB08911	Trametinib	2	Unknown Status	1
DB00135	Tyrosine	2	Recruiting	1
DB05294	Vandetanib	2	Completed	2
DB05294	Vandetanib	2	Terminated	1
DB05238	Vemurafenib	2	Active Not Recruiting	1
DB08881	Vemurafenib	2	Active Not Recruiting	1
DB05153	Cabozantinib	3	Completed	1
DB08875	Cabozantinib	3	Completed	1
DB09078	Lenvatinib	3	Completed	1
DB00331	Metformin	3	Not Yet Recruiting	1
DB09100	Thyroid, porcine	3	Unknown Status	1
DB00024	Thyrotropin alfa	3	Unknown Status	1
DB05294	Vandetanib	3	Active Not Recruiting	1
DB00316	Acetaminophen	4	Completed	1
DB00318	Codeine	4	Completed	1
DB16024	Indocyanine green	4	Completed	1
DB00451	Levothyroxine	4	Terminated	1
DB09161	Technetium Tc-99m sestamibi	4	Terminated	1
DB00024	Thyrotropin alfa	4	Completed	1
DB00193	Tramadol	4	Completed	1
DB05294	Vandetanib	4	Active Not Recruiting	1
DB00136	Calcitriol	Not Available	Not Yet Recruiting	1
DB01373	Calcium	Not Available	Not Yet Recruiting	1
DB06724	Calcium carbonate	Not Available	Not Yet Recruiting	1
DB14554	Dotatate	Not Available	Recruiting	1
DB15107	Fludeoxyglucose	Not Available	Withdrawn	1
DB16024	Indocyanine green	Not Available	Recruiting	1
DB09420	Iodide I-123	Not Available	Withdrawn	1
DB09293	Iodide I-131	Not Available	Completed	2
DB12217	Iodide I-131	Not Available	Completed	1
DB05382	Iodine	Not Available	Withdrawn	1
DB09078	Lenvatinib	Not Available	Approved for Marketing	1
DB00451	Levothyroxine	Not Available	Completed	1
DB00281	Lidocaine	Not Available	Completed	2
DB00281	Lidocaine	Not Available	Unknown Status	1
DB00279	Liothyronine	Not Available	Completed	1
DB14513	Magnesium	Not Available	Completed	1
DB11689	Selumetinib	Not Available	Completed	1
DB01268	Sunitinib	Not Available	Completed	1
DB09100	Thyroid, porcine	Not Available	Completed	1
DB09100	Thyroid, porcine	Not Available	Not Yet Recruiting	1
DB00024	Thyrotropin alfa	Not Available	Completed	1
DB13930	Ulixertinib	Not Available	Available	1